London, the U.K-based digital-first home healthcare firm Cera raises USD 320 million in the latest funding. The round took place on August 4, 2022. The financing is a blend of equity and debt. Cera’s existing investor Kairos HQ led the round for the company.
Vanderbilt University Endowment, Evolve Healthcare Partners alongside Schroders Capital, Jane Street Capital, Yabeo Capital participated in the financing. Meanwhile the round saw Squarepoint Capital, Guinness Asset Management, Oltre Impact, 8090 Partners’ participation. Technology investor Robin Klein as well as several other international institutional investors joined in the funding.
Purpose of Funding for Cera
With the latest capital infusion, Cera intends to expand its tech-enabled health services daily from 15,000 to 100,000 at-home patients. Meanwhile, it aims to free up NHS beds and boost the UK’s care capacity by over 50 hospitals.
The new proceeds will aid in increasing the number of patients in its care by over 5-fold by 2025. The move aligns with Cera’s mission to empower patients to live longer, healthier lives in their own homes through technology.
Meanwhile, the healthcare company has plans to diversify its investment in nursing, telehealth and prescription delivery services, both in the UK and internationally.
What the Cera officials have to say
Dr Ben Maruthappu MBE, CEO and Co-founder of Cera, said, “Since Cera’s launch in November 2016, the company has scaled at an unprecedented rate for the sector, benefiting countless lives, and proving the need for technology-powered improvement in healthcare. Receiving such significant financial backing during this period of global economic volatility is a testament to the strength of Cera’s business model, our innovation, and our commitment to revolutionising healthcare. We’re now in pole position to be able to use our unique technology to expand what we do for patients across the world who are in need of care while relieving pressures on public services.”
Sir David Behan, CBE, Chair of Cera’s Advisory Board and former CEO of the Care Quality Commission, added: “Governments around the world have been searching for solutions to the ongoing challenges in healthcare. Cera’s blend of cutting-edge technology and truly compassionate carers represent the future of health and social care in the UK and beyond. Cera has already transformed the lives of tens of thousands of people, helped the UK Government to employ carers during the COVID-19 pandemic, and created and implemented technology that gives carers, those they care for and their families peace of mind while also giving them the freedom to live their lives in the comfort of their own homes. Cera’s Next Chapter will take that further to more people who require care, more countries and with more technological innovations.”
What the investor has to say
Tim Creed, Head of Private Equity Investments of Schroders Capital, said, “Ageing populations, post-pandemic recovery and major staff shortages have created a series of issues facing healthcare providers and governments. Cera’s proposition is proven to deliver results in facing down these challenges. Cera’s digital-first home healthcare is a unique offering that we believe must be rolled out far and wide to provide a tangible solution to hospital waiting times, build a bigger carer workforce and help our elderly communities to receive quality, genuine care. We’re proud to be a partner of Cera and to play a part in supporting their mission to empower people to live longer, better lives in their own homes through technology.”
About Cera
Mahiben Maruthappu, Dr Ben Maruthappu and Marek Sacha launched the company in 2016. The U.K-based company has operations in Germany. It delivers care, nursing, telehealth and prescription delivery services in the home, supported by technology. The healthcare firm is ten times more affordable than a patient receiving care in a hospital.
For more extensive analysis and Market Intelligence reports, feel free to approach us.
We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know
if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover
–what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!
Next Article
